ever, such richer data may be collected as the need arises, rather than on the regular schedule that is basic to the monitoring function. Data needs for analysis of particular drug control instruments are discussed in Part III.1


The committee invited officials at a number of public agencies and private organizations to comment on the accuracy of descriptions of their programs that are discussed in the rest of this report. These agencies and organizations include: the Office of National Drug Control Policy, the National Institute on Drug Abuse, the National Institute of Justice, the Bureau of Justice Statistics, the Substance Abuse and Mental Health Services Administration, the Centers for Disease Control and Prevention, and the Institute for Defense Analyses. The committee’s written requests and the comments of those who replied to them can be found in the public access file for this study.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement